PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: KDM Communications Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Pro-Lab Diagnostics Launches Prolisa™ Cryptosporidium/Giardia Enzyme Immunoassay - Pro-Lab Diagnostics has developed a new enzyme immunoassay (EIA) for the qualitative detection of Cryptosporidium and Giardia lamblia antigens in human faecal specimens from patients displaying gastrointestinal symptoms - Pro-Lab.com
Pro-Lab Diagnostics Launches Prolisa™ Cryptosporidium/Giardia Enzyme Immunoassay

 

NewswireToday - /newswire/ - St Neots, Cambridgeshire, United Kingdom, 2012/02/24 - Pro-Lab Diagnostics has developed a new enzyme immunoassay (EIA) for the qualitative detection of Cryptosporidium and Giardia lamblia antigens in human faecal specimens from patients displaying gastrointestinal symptoms - Pro-Lab.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The Prolisa™ Cryptosporidium/Giardia EIA kit offers precise results with high sensitivity and excellent specificity, enabling accurate diagnosis of infection.

Cryptosporidiosis is routinely diagnosed by microscopic analysis of stool samples using organic dyes or by immunostaining by direct fluorescent antibody, and can be difficult to detect. Similarly, Giardia infection is frequently misdiagnosed, relying on poorly performing antigen-based testing. Pro-Lab Diagnostics’ Prolisa™ Cryptosporidium/Giardia EIA is a convenient, rapid and easy-to-use method of detecting Cryptosporidium and G. lamblia. Supplied in a 96-well test size consisting of detachable stripwells, this manual assay uses monoclonal anti-Cryptosporidium and anti- G. lamblia antibodies to ensure excellent sensitivity and specificity for high value diagnostic results, and can also be performed on most automated platforms for increased workflow flexibility. Mark Reed, General Manager of Pro-Lab Diagnostics, commented: “The launch of the Cryptosporidium/Giardia EIA further extends the Prolisa product range, offering our customers a simple and cost-effective alternative means of testing for Cryptosporidiosis and Giardiasis with the back-up support of our team of application experts.”

About Pro-Lab Diagnostics

The Pro-Lab Group of companies (pro-lab.com) is dedicated to the provision of high quality, cost effective immunodiagnostic products and biological reagents to hospitals, private medical laboratories, veterinary laboratories, and other biological investigative laboratories. Pro-Lab Diagnostics is a privately held corporation founded in 1974 with its head office in Toronto, Canada and subsidiaries in the U.K. and U.S.A.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: KDM Communications Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Pro-Lab Diagnostics Launches Prolisa™ Cryptosporidium/Giardia Enzyme Immunoassay

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Sophie Woodward - KDM-Communications.com 
+44(0)15 1353 1613 uksupport[.]pro-lab.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any KDM Communications Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From KDM Communications Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)